Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab Population

PURPOSE: Antiangiogenic tyrosine kinase inhibitors have been the mainstay first-line therapy for metastatic renal cell carcinoma (mRCC). We reviewed the efficacy of first-line therapy with sunitinib in patients with mRCC in an Arab population. METHODS: Medical records of patients with mRCC treated a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Glob Oncol
Main Authors: Badran, Ahmed, Elshenawy, Mahmoud A., Shahin, Amgad, Aljubran, Ali, Alzahrani, Ahmed, Eldali, Abdelmoneim, Bazarbashi, Shouki
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6998020/
https://ncbi.nlm.nih.gov/pubmed/32031432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.19.00111
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados